| 1 |
35153800 | Using Polyacrylamide Hydrogels to Model Physiological Aortic Stiffness Reveals that Microtubules Are Critical Regulators of Isolated Smooth Muscle Cell Morphology and Contractility. | 2022 |
1 |
| 2 |
27432870 | Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function. | 2016 Sep |
1 |
| 3 |
25228510 | Rho-kinase inhibitor reduces hypersensitivity to ANG II in human mesenteric arteries retrieved and conserved under the same conditions as transplanted organs. | 2014 Aug 22 |
3 |
| 4 |
22842919 | Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway. | 2012 Oct |
1 |
| 5 |
21271181 | Angiotensin II induces NF-κB, JNK and p38 MAPK activation in monocytic cells and increases matrix metalloproteinase-9 expression in a PKC- andRho kinase-dependent manner. | 2011 Mar |
1 |
| 6 |
18633694 | Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. | 2008 Oct |
1 |
| 7 |
16684954 | Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts. | 2006 Jun |
1 |
| 8 |
16957559 | Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation. | 2006 Oct |
1 |
| 9 |
15194453 | Growth factor-induced contraction of human bronchial smooth muscle is Rho-kinase-dependent. | 2004 Jun 21 |
1 |
| 10 |
11348889 | Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. | 2001 May |
1 |